ethinyl estradiol has been researched along with metronidazole in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Back, DJ; Breckenridge, AM; Purba, HS | 1 |
| Diddle, AW | 1 |
| Chowdhury, V; Gupta, K; Hazari, K; Joshi, JV; Joshi, UM; Krishna, U; Mandlekar, A; Sankholi, GM; Saxena, BN; Sheth, UK | 1 |
| Keck, L; Shariff, A; Zlotoff, B | 1 |
| Adetoro, N; Braun, CJ; Pentikis, HS | 1 |
1 trial(s) available for ethinyl estradiol and metronidazole
| Article | Year |
|---|---|
Lack of a Pharmacokinetic Interaction Between SYM-1219 Granules Containing 2 Grams of Secnidazole and a Combined Oral Contraceptive in a Phase 1, Randomized, Open-Label Study in Healthy Female Volunteers.
Topics: Adult; Contraceptives, Oral, Combined; Drug Interactions; Ethinyl Estradiol; Female; Humans; Metronidazole; Middle Aged; Vaginosis, Bacterial | 2017 |
12 other study(ies) available for ethinyl estradiol and metronidazole
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Inhibition of estrogen 2-hydroxylase.
Topics: Animals; Antipyrine; Chloroquine; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP1A1; Diethylstilbestrol; Estradiol; Ethinyl Estradiol; Imidazoles; Kinetics; Male; Metronidazole; Microsomes, Liver; Primaquine; Rats; Rats, Inbred Strains; Steroid Hydroxylases | 1986 |
Trichomonas vaginalis: resistance to metronidazole.
Topics: Adult; Antiprotozoal Agents; Arsenicals; Borates; Carbohydrates; Ethinyl Estradiol; Female; Humans; Metronidazole; Nystatin; Penicillin Resistance; Penicillins; Progestins; Respiratory Tract Infections; Trichomonas Vaginitis | 1967 |
A study of interaction of low-dose combination oral contraceptive with Ampicillin and Metronidazole.
Topics: Adult; Ampicillin; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Interactions; Ethinyl Estradiol; Female; Humans; Metronidazole; Norethindrone; Statistics as Topic | 1980 |
Acne vulgaris in the context of complex medical co-morbities: the management of severe acne vulgaris in a female with retinitis pigmentosa - utilizing pulse dye laser in conjunction with medical therapy.
Topics: Acne Vulgaris; Administration, Cutaneous; Adult; Androstenes; Anti-Infective Agents, Local; Combined Modality Therapy; Contraindications; Dapsone; Dicarboxylic Acids; Ethinyl Estradiol; Female; Humans; Lasers, Dye; Metronidazole; Mineralocorticoid Receptor Antagonists; Photosensitizing Agents; Retinal Detachment; Retinitis Pigmentosa; Rosacea; Sulfacetamide; Telangiectasis | 2014 |